The IMID Forum

← The IMID Forum16. Juli · 24 Min.

Discussing axSpA: Long-term safety and efficacy of bimekizumab and ixekizumab in r-axSpA

Discussing axSpA: Long-term safety and efficacy of bimekizumab and ixekizumab in r-axSpA16. Juli24 Min.

Join Dr Sofia Ramiro and Professor Atul Deodhar as they discuss the top publications in the world of axSpA. This month, the conversation covered the long-term safety and efficacy of bimekizumab and ixekizumab in r-axSpA.